Skip to main content

North America Contributed Maximum Share to the Global In-Silico Drug Discovery Market in 2018

 

Drug discovery is used for the identification of the lead structure, which is followed by the synthesis of its analogs, and the latter’s screening to get candidate molecules for drug development. The objective of the drug discovery process is to search for new drug molecules that can bind to a specific target. Further, in the traditional drug discovery process, identifying the suitable drug target is the first and foremost task.

The different steps associated with the in-silico drug discovery process include target identification, target validation, lead identification, lead optimization, pre-clinical studies, and clinical trials. The market for in-silico drug discovery is focused on software, services, and artificial intelligence. Advanced software and informatics deliver far more insight than traditional methods, with a resolution significantly higher than ever before.

According to the market study published by BIS Research, the in-silico drug discovery market was estimated at $2,094.5 million in 2018 and is expected to grow at a CAGR of 12.92% during the forecast period 2019-2029.

The global in-silico drug discovery market was segmented on the basis of end-users, including contract research organizations (CRO), pharmaceutical industry, academic and research institutes, and other end users (hospitals and other care facilities).

Recently, in-silico drug discovery has gained a lot of popularity. The major reason for drug discovery’s popularity is the analysis of data generated from different technologies such as next-generation sequencing and non-invasive or minimally invasive diagnostic technologies. Due to the application of informatics, tools such as data semantics and visual analytics are being used in the industry. The usage of these tools has increased research effectiveness, improved predictability, and fostered effective teamwork among scientists. The pharmaceutical industry contributed the maximum share in 2018 and is expected to dominate the market share in the future as well.

In addition, as per the regional data of the in-silico drug discovery market, North America contributed the maximum to the market. However, it is the region of Asia-Pacific that is expected to grow with the highest CAGR during the forecast period from 2019 to 2029.

Labels:

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

Understanding How the Human Centric Lighting Market is Segmented

Lighting plays a significant role in the lives of people, it has the potential to bring about positive changes in people’s behaviour. In the year 1989, a research was carried out and it proved that natural daylight can trigger the production of melatonin and serotonin, two of the most important hormones in the human body. These two hormones are responsible for inducing peaceful sleep and happiness in people. This led to the research and development in the field of human centric lighting (HCL). According to a report published by the BIS Research , the HCL market is expected to grow at a CAGR of 37.2% and 35.2% both in terms of volume and value during the forecast period (2018 – 2024). The HCL is segmented by the component, end-user and by region. Request the Sample: Human Centric Lighting Market The human centric lighting market can be further segmented by component, type, end-users, and region. The components or the controls are further segmented as microprocessors & microco...
Post a Comment
Read more

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more